NCT04269876 is a NA clinical trial of Marine Lipid Oil Concentrate in Inflammation, sponsored by Supplement Formulators, Inc..

Who is sponsoring NCT04269876?

NCT04269876 is sponsored by Supplement Formulators, Inc..

What drugs are being tested in NCT04269876?

Interventions in NCT04269876: Marine Lipid Oil Concentrate, Dietary Supplement, Placebo, Placebo.

What condition does NCT04269876 study?

NCT04269876 studies Inflammation, Inflammatory Response.

Is NCT04269876 still recruiting?

NCT04269876 is currently terminated. Last updated 13 January 2023.

Last reviewed 2023-01-13 · How we verify

NCT04269876

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Study to Evaluate the Effects of a Marine Lipid Oil Concentrate Formulation on Inflammation

Terminated NA Last updated 13 January 2023

What this trial tests

NA trial testing Marine Lipid Oil Concentrate in Inflammation in 8 participants. Terminated before completion.

Timeline

31 October 2019

Primary endpoint
30 September 2021

30 September 2021

Quick facts

Lead sponsor	Supplement Formulators, Inc.
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	health services research
Enrollment	8
Start date	31 October 2019
Primary completion	30 September 2021
Estimated completion	30 September 2021
Sites	1 location across United States

Drugs / interventions tested

Marine Lipid Oil Concentrate
Dietary Supplement — full drug profile →
Placebo
Placebo

Conditions studied

Inflammation — all drugs for Inflammation →
Inflammatory Response — all drugs for Inflammatory Response →

Sponsor

Supplement Formulators, Inc.

Who can join

Adults 35 to 75, any sex, with Inflammation or Inflammatory Response. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To assess the efficacy and safety of a Marine Lipid Oil Concentrate formulation on inflammatory biomarkers and overall well-being in male and female subjects who are overweight to mildly obese, but otherwise generally healthy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy.
Sansone C, Bruno A, Piscitelli C, Baci D, et al · · 2021 · cited 39× · PMID 33504012 · DOI 10.3390/cells10020231

Verify or expand the search:

Other recruiting trials for Inflammation

Currently open trials in the same condition.

NCT07341087 — Skin Inflammation in Perimenopause: A Probiotic Intervention Proof of Concept Trial · NA · recruiting
NCT07479940 — Obesity and Aging: Impacts of Nutritional Counseling and Physical Exercise on Telomeres and Senescence Parameters · NA · active not recruiting
NCT07269847 — Comparing a Healthy Beef-Centric Diet to a Healthy U.S.-Style Diet on Metabolic Health Outcomes in Pre-Diabetic Adults · NA · recruiting
NCT07171450 — Cognitive Remediation · NA · recruiting
NCT07411612 — The Association Between Postoperative Inflammatory and Neurological Serum Biomarker Concentrations and Occurrence of Pos · recruiting

Other Supplement Formulators, Inc. trials

Trials by the same sponsor.

NCT07371975 — A Study to Evaluate the Effects of a Butyrate-Polyphenol Formulation on Gut Health and Associated Symptoms · NA · recruiting
NCT06419231 — Effectiveness of a Butyrate Formulation and Butyrate + Polyphenol Formulation on Gut Health, Permeability and Associated · NA · completed
NCT05854017 — Effects of a Theanine for Stress Relief Formulation in Individuals Who Report Occasional Moderate High Levels of Stress. · NA · active not recruiting
NCT05450952 — Evaluate the Effects of a Theanine Formulation on Stress, Burnout, Mood, and Sleep in Individuals Who Report Occasional · NA · terminated
NCT05170113 — Evaluate the Effectiveness and Safety of the Alpinia Galanga Formulation, Theacrine Formulation, and Caffeine Formulatio · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04269876 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Supplement Formulators, Inc.
Last refreshed: 13 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04269876.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing